NCT07487350 Recurrent Visceral Leishmaniasis in HIV Co-Infection
| NCT ID | NCT07487350 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Institute of Tropical Medicine, Belgium |
| Condition | Hiv |
| Study Type | OBSERVATIONAL |
| Enrollment | 20 participants |
| Start Date | 2025-10-21 |
| Primary Completion | 2027-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 20 participants in total. It began in 2025-10-21 with a primary completion date of 2027-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim is (1) to better understand the underlying causes and predispositions for relapse and parasite persistence in visceral leishmaniasis (VL) patients living with HIV and (2) to improve treatment monitoring of this target group in Ethiopia
Eligibility Criteria
Inclusion Criteria: 1. VL-HIV infection 1.1. VL: microscopically confirmed parasite presence in spleen or bone marrow tissue at first episode or relapse; for known active chronic cases: decision to treat VL 1.2. HIV: confirmed viral infection (new or past) 2. ≥18 years Exclusion Criteria: 1. Not willing to provide written informed consent 2. Not willing to adhere to the follow-up visits 3. Mentally or physically incapable to participate in the study (to the discretion of the treating physician)
Contact & Investigator
Eleni Ayele
PRINCIPAL INVESTIGATOR
LRTC University of Gondar
Frequently Asked Questions
Who can join the NCT07487350 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Hiv. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07487350 currently recruiting?
Yes, NCT07487350 is actively recruiting participants. Contact the research team at nberens@itg.be for enrollment information.
Where is the NCT07487350 trial being conducted?
This trial is being conducted at Gonder, Ethiopia.
Who is sponsoring the NCT07487350 clinical trial?
NCT07487350 is sponsored by Institute of Tropical Medicine, Belgium. The principal investigator is Eleni Ayele at LRTC University of Gondar. The trial plans to enroll 20 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.